Abstract
Pterygium recurrence is one of the most common complications in pterygium surgery. And various medicines combined with surgery could further reduce the rates of recurrence. As traditional adjunctive therapies, anti-metabolic drugs have been applied to prevent the recurrence of pterygium for decades. However, mitomycin C has been not available because of its shortage source, and 5-fluorouracil is less effective. Recently, some medicines such as anti-vascular endothelial growth factor agents, cyclosporine A and interferon, characterized by anti-proliferation and anti-angiogenesis, provide new approaches to prevent the recurrence of pterygium. However, the high costs of above medicines and uncertain long-term effects are still huge problems. (Int Rev Ophthalmol, 2018, 42: 129-133) Key words: pterygium; recurrence; drugs
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
